We explored the effects of different genetic alterations and LIGHT-binding proteins, which could help researchers investigate the potential molecular mechanism of LIGHT in the pathogenesis or clinical prognosis of LGG and GBM. The gene discussed is TNFSF14; the disease is glioblastoma.